The National Cancer Institute collaborated with the Department of Health and Human Services to establish National Network of Tobacco Cessation Quitlines
| | | | | |

The National Cancer Institute collaborated with the Department of Health and Human Services to establish National Network of Tobacco Cessation Quitlines

In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…

Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer
| | | | | | |

Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer

In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…

World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.
| | | | | | |

World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.

In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…

A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors
| | | | | |

A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors

On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…

Drs. Judith James and John Harley at the OMRF published an important study that showed certain antibodies for lupus were typically present years before the disease with diagnosed
| | |

Drs. Judith James and John Harley at the OMRF published an important study that showed certain antibodies for lupus were typically present years before the disease with diagnosed

On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…

A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence
| | | | | |

A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence

On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…